A Pilot Study of the Efficacy and Safety of Faecal Microbiota Transplant for the Treatment of Immune Checkpoint Inhibitor Colitis (ACTRN12624000120572)

FMT-CHECKPOINT

This trial is Currently recruiting
Registration number ACTRN12624000120572

Program & service

This trial is being run with the Specialty Medicine service, and as part of the Gastroenterology program.

Trial phase

Pilot

Trial participation type

This trial is for clinical research of something other than a drug or device.

Principal investigator

Professor Alexander Boussioutas

More information

To find out more about this clinical trial, please review full details on the ANZCTR website.

View on ANZCTR

If you would like further details or have any questions about this clinical trial, we encourage you to get in touch with us and a member of our team will be happy to provide you with more information.